Ventyx Biosciences Inc (VTYX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $13.97
• Market Cap: $1.00B
• EPS: $-1.49
• 52-Week High: $15.34
• 52-Week Low: $0.78

Market Sentiment

Ventyx Biosciences Inc currently has a Neutral sentiment score of 0.12.

About Ventyx Biosciences Inc

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Encinitas, California, dedicated to developing novel small molecule therapeutics for inflammatory and autoimmune disorders. The company is advancing a promising pipeline of drug candidates that target critical pathways involved in these diseases, aiming to meet substantial unmet medical needs. With a robust emphasis on research and development, Ventyx is well-positioned to provide innovative treatment solutions th...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Ventyx Biosciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VTYX pay dividends?

Ventyx Biosciences Inc (VTYX) does not currently pay a regular dividend.

What is VTYX's market cap?

Ventyx Biosciences Inc (VTYX) has a market capitalization of $1.00B with a current stock price of $13.97.